-+ 0.00%
-+ 0.00%
-+ 0.00%

Indivior Data Presented At Academy Of Managed Care Pharmacy Demonstrates Potential Of SUBLOCADE To Treat Opioid Use Disorder

Benzinga·11/03/2025 13:12:24
Listen to the news

Indivior PLC (Nasdaq: INDV) presented three new scientific posters at the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 conference last week, showcasing real-world evidence on the clinical and economic impact of monthly injectable buprenorphine in the treatment of OUD. The data highlights the potential of SUBLOCADE to improve patient outcomes while reducing healthcare resource utilization across both Medicaid and commercially insured populations.